In childern, most common posterior fossa tumour is-
**Question:** In children, the most common posterior fossa tumor is:
A. Medulloblastoma
B. Pilocytic astrocytoma
C. Ependymoma
D. Meningioma
**Core Concept:** Posterior fossa tumors are a group of brain tumors that arise in the cerebellum, brainstem, or fourth ventricle. These tumors can affect a child's neurological function, including coordination, speech, and vision.
**Why the Correct Answer is Right:** Medulloblastoma is the most common posterior fossa tumor in children. It is a malignant tumor that arises from the neuroepithelial cells of the cerebellum, particularly the vermis. Medulloblastoma typically presents with symptoms related to increased intracranial pressure, such as headache, vomiting, and seizures. It usually spreads through the cerebrospinal fluid (CSF) pathways, explaining its common involvement of the posterior fossa and spinal cord.
**Why Each Wrong Option is Incorrect:**
B. Pilocytic astrocytoma (Brainstem glioma): Although this tumor is generally benign, it can still cause symptoms related to increased intracranial pressure, such as headache and seizures. However, it arises from astrocytes in the brainstem, not the posterior fossa.
C. Ependymoma: These tumors arise from ependymal cells lining the ventricles and spinal cord. While they can affect the posterior fossa, they are less common compared to medulloblastoma.
D. Meningioma: These tumors are typically benign tumors that arise from the meninges. Although meningiomas can occur in the posterior fossa, medulloblastoma remains the most common posterior fossa tumor in children.
**Clinical Pearl:** In children presenting with symptoms of posterior fossa involvement, it is essential to consider medulloblastoma among the differential diagnoses. Imaging studies, such as computed tomography (CT) or magnetic resonance imaging (MRI), are crucial in diagnosing these tumors. Once diagnosed, appropriate treatment, including surgery, radiation therapy, and chemotherapy, can improve the prognosis and overall survival of pediatric patients.